Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
David F. Yankelevitz, MD
Professor
Radiology
Icahn School of Medicine at Mount Sinai
New York
Professor, Radiology, Icahn School of Medicine at Mount Sinai, New York
Authored Items
Concerns Related to Benefits and Harms of Real-World Shared Decision-Making for Lung Cancer Screening
James L. Mulshine, MD
,
David F. Yankelevitz, MD
,
Bruce S. Pyenson, FSA, MAAA
Web Exclusives
in
Perspectives
Offering Lung Cancer Screening to High-Risk Medicare Beneficiaries Saves Lives and Is Cost-Effective: An Actuarial Analysis
Joseph R. Antos, PhD
,
Ellynne Dec, ASA, MAAA
,
Claudia I. Henschke, PhD, MD
,
David F. Yankelevitz, MD
,
Rowena Yip, MPH
,
Bruce S. Pyenson, FSA, MAAA
August 2014 Vol 7, No 5
in
Regulatory
Last modified: August 29, 2014